Skip to menu Skip to content Skip to footer

2006

Conference Publication

Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome

Barbour, AP, Beller, E and Smithers, BM (2006). Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome. 59th Annual Cancer Symposium of the Society-of-Surgical-Oncology, San Diego CA, MAR 23-26, 2006. NEW YORK: SPRINGER.

Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome

2006

Journal Article

Radiotherapy for metastatic melanoma presenting in pregnancy

Daly, T., Burmeister, B, Smithers, B M, Doody, J. and Kane, A. (2006). Radiotherapy for metastatic melanoma presenting in pregnancy. Australasian Radiology, 50 (6), 598-603. doi: 10.1111/j.1440-1673.2006.01641.x

Radiotherapy for metastatic melanoma presenting in pregnancy

2006

Conference Publication

Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour response

Barbour, A. P., Smithers, B. M., Gotley, D. C., Thomas, J., Burmeister, B. H. and Thompson, D. (2006). Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour response. The RACS Annual Scientific Congress, Sydney Convention & Exhibition Centre, Darling Harbour, Sydney, 15-19 May, 2006. Australia: Blackwell Publishing Asia.

Refining oesophageal cancer staging after neoadjuvant therapy: importance of primary tumour response

2006

Journal Article

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06

Burmeister, Bryan H., Smithers, B. Mark, Burmeister, Elizabeth, Baumann, Kathryn, Davis, Sidney, Krawitz, Hedley, Johnson, Carol and Spry, Nigel (2006). A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiotherapy and Oncology, 81 (2), 136-142. doi: 10.1016/j.radonc.2006.10.001

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96.06

2006

Journal Article

Minimally invasive esophagectomy

Leibman, S., Smithers, B. M., Gotley, D. C., Martin, I. and Thomas, J. (2006). Minimally invasive esophagectomy. Surgical Endoscopy And Other Interventional Techniques, 20 (3), 428-433. doi: 10.1007/s00464-005-0388-y

Minimally invasive esophagectomy

2006

Conference Publication

Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome

Barbour, A.P., Beller, E. and Smithers, B.M. (2006). Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome. The 59th Annual Cancer Symposium of the Society of Surgical Oncology, San Diego, CA, 23-26 March 2006. Hagerstown, U.S.A.: Springer.

Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome

2005

Journal Article

Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *

Smith, Louise, Smithers, Mark, Prins, Johannes and O'Moore-Sullivan, Trisha (2005). Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *. The Australian and New Zealand Journal of Surgery, 75 (12), 1124-1126. doi: 10.1111/j.1445-2197.2005.03628.x

Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *

2005

Journal Article

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply

Burmeister, Bryan H. and Smithers, B. Mark (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply. Lancet Oncology, 6 (11), 825-825. doi: 10.1016/S1470-2045(05)70402-2

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply

2005

Journal Article

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus

Smith, Kylie J., O'Brien, Suzanne M., Smithers, B. Mark, Gotley, David C., Webb, Penelope M., Green, Adèle C. and Whiteman, David C. (2005). Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiology Biomarkers & Prevention, 14 (11), 2481-2486. doi: 10.1158/1055-9965.EPI-05-0370

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus

2005

Journal Article

Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply

Burmeister, Bryan H. and Smithers, B.Mark (2005). Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply. Lancet Oncology, 6 (11), 825-826. doi: 10.1016/S1470-2045(05)70402-2

Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply

2005

Journal Article

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery

Byrne, J. P., Smithers, B. M., Nathanson, L. K., Martin, I., Ong, H. S. and Gotley, D. C. (2005). Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery. British Journal of Surgery, 92 (8), 996-1001. doi: 10.1002/bjs.4914

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery

2005

Conference Publication

Preoperative adjuvant chemoradiation therapy for localised oesophageal cancer – study 9401 and the aftermath

Burmeister, B. H. and Smithers, B. M. (2005). Preoperative adjuvant chemoradiation therapy for localised oesophageal cancer – study 9401 and the aftermath. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting 2005, Brisbane, Australia, 16-18 November, 2005. Blackwell Publishing Asia. doi: 10.1111/j.1743-7563.2005.00027.x

Preoperative adjuvant chemoradiation therapy for localised oesophageal cancer – study 9401 and the aftermath

2005

Journal Article

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin

Burmeister, B., Walpole, E. T., Burmeister, E., Thomas, J., Thomson, D. B., Harvey, J., Smithers, B. M. and Gotley, D. C. (2005). Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. International Journal of Clinical Oncology, 10 (4), 256-261. doi: 10.1007/s10147-005-0506-9

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin

2005

Journal Article

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Burmeister, B. H., Smithers, B. M., Gebski, V., Fitzgerald, L., Simes, R. J., Devitt, P., Ackland, S., Gotley, D. C., Joseph, D., Millar, J., North, J., Walpole, E. T. and Denham, J. W. (2005). Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncology, 6 (9), 659-668. doi: 10.1016/S1470-2045(05)70288-6

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

2005

Journal Article

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

Pramesh, C. S., Mistry, Rajesh C., Laskar, Sarbani G., Burmeister, Bryan H. and Smithers, B. Mark (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer. Lancet Oncology, 6 (11), 824-825. doi: 10.1016/S1470-2045(05)70401-0

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

2005

Conference Publication

A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06

Burmeister, B. H., Smithers, B. M., Burmeister, E. A., Baumann, K. C., Davis, S. R., Krawitz, H., Johnson, C. and Spry N. (2005). A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting 2005, Brisbane, QLD Australia, 16-18 November 2005. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1743-7563.2005.00027.x

A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06

2005

Journal Article

Novel approach to oesophageal resection

Smithers, Mark (2005). Novel approach to oesophageal resection. ANZ Journal of Surgery, 75 (12), 1029-1029. doi: 10.1111/j.1445-2197.2005.03661.x

Novel approach to oesophageal resection

2004

Journal Article

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia

Harvey, J. A., Bessell, J. R., Beller, E., Thomas, J., Gotley, D. C., Burmeister, B. H., Walpole, E. T., Thomson, D. B., Martin, I., Doyle, L., Burmeister, E. and Smithers, B. M. (2004). Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Diseases of The Esophagus, 17 (3), 260-265. doi: 10.1111/j.1442-2050.2004.00420.x

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia

2004

Book Chapter

Isolated limb perfusion and infusion: preclinical studies and future directions

Smithers, B. Mark and De Wilt, Johannes H. W. (2004). Isolated limb perfusion and infusion: preclinical studies and future directions. Textbook of Melanoma. (pp. 438-442) edited by Thompson, John F., Morton, Donald L. and Kroon, Bin B.R.. London, United Kingdom: Martin Dunitz.

Isolated limb perfusion and infusion: preclinical studies and future directions

2004

Book Chapter

Skin Cancer and Melanoma

Burmeister, B. H., Poulsen, M., Smithers, B. M., Kennedy, D. and Thompson, D. (2004). Skin Cancer and Melanoma. UICC Manual for Clinical Oncology. (pp. 319-334) edited by R. E. Pollock, J. H. Doroshow, D. Khayat, A. Nakao and B. O'Sullivan. Hoboken, N.J.: Wiley-Liss.

Skin Cancer and Melanoma